ResearchMoz

Global Array Instruments Market 2012-2016

Technavio
Published Date » 2013-01-09
No. Of Pages » 43
   
 TechNavio's analysts forecast the Global Array Instruments market to grow at a CAGR of 14.29 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in technological innovations. The Global Array Instruments market has also been witnessing the trend of increasing market consolidation. However, the intense competition among vendors could pose a challenge to the growth of this market. 
   
 TechNavio's report, the Global Array Instruments Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Array Instruments market landscape and its growth prospects in the coming years. The report also...
Table of Contents: 

1. Executive Summary

2. Introduction

3. Market Coverage
Market Overview
Key Offerings

4. Market Landscape
4.1 Global Array Instruments Market
Market Size and Forecast
4.2 Market Segmentation of Array Instruments
4.3 Five Forces Analysis

5. Geographical Segmentation

6. Vendor Landscape

7. Buying Criteria

8. Market Growth Drivers

9. Drivers and Their Impact

10. Market Challenges

11. Impact of Drivers and Challenges

12. Market Trends

13. Key Vendor Analysis
13.1 Affymetrix Inc.
Business Overview
Key Information
SWOT Analysis
13.3 Illumina Inc.
Business Overview
Key Information
SWOT Analysis
13.4 Agilent Technologies Inc.
Business Overview
Key Information
SWOT Analysis
13.5 Roche Diagnostics Corp.
Business Overview
Key Information
SWOT Analysis

14. Other Reports in this Series

List of Tables


List of Figures


Exhibit 1: Global Array Instruments Market 2012-2016 (US$ million)
Exhibit 2: Global Array Instruments Market Segmentation
Exhibit 3: Global Array Instruments Market Segmentation 2012
Exhibit 4: Global Array Instruments Market by Revenue 2012-2016 (US$ million)
Exhibit 5: Global Array Instruments Market 2012-2016 (percent)
Exhibit 6: Global Array Instruments Market by Geographical Segmentation 2012

Upcoming Reports:

Poland: textile sacks and bags market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the textile sacks and bags market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the textile sacks and bags market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...
Poland: market of ammonium nitrate mixtures
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the ammonium nitrate mixtures market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the ammonium nitrate mixtures market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an...
Chronic Stable Angina Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Angina is a kind of chest pain or discomfort caused by poor flow of blood in the heart. This often occurs due to narrowing of blood arteries (atherosclerosis) caused by plaque formation or blood clot. People with obesity, history of heart disease, diabetes, high level of blood cholesterol and smoking are high risk of getting affected with angina. Some common symptoms associated with angina include pain, pressure or strange feeling in chest, shortness of breath, lightheadedness, irregular heartbeat, nausea or vomiting and weakness. Angina may be of two types: stable angina and unstable...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...